AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36156799 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MedD)
Number of subjects: 37
Study 36156799 — intervention group
Group type: COMPARATOR
Intervention: Western diet (Control group)
Number of subjects: 37
Study 33119491 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (1.5 mA for 20 minutes)
Number of subjects: 33
Study 33119491 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 33
Study 33294804 — intervention group
Group type: EXPERIMENTAL
Intervention: Landiolol plus conventional sepsis therapy
Number of subjects: 151
Study 33294804 — intervention group
Group type: COMPARATOR
Intervention: Conventional sepsis therapy alone (control group)
Number of subjects: 151
Study 34949538 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-mg hyoscine butylbromide (HBB)
Number of subjects: 111
Study 34949538 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 111
Study 36183113 — intervention group
Group type: EXPERIMENTAL
Intervention: Alum-adjuvanted rabies vaccine (ARV)
Number of subjects: 0
Study 36183113 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-adjuvanted rabies vaccine (NRV)
Number of subjects: 0
Study 36183113 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33834520 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 0
Study 33183662 — intervention group
Group type: EXPERIMENTAL
Intervention: Carrot seed (500 mg three times a day for 12 weeks)
Number of subjects: 68
Study 33183662 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 36315128 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg daily after a 1-month phase of 40 mg daily
Number of subjects: 235
Study 36315128 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 235
Study 32787361 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolong life with nine turn method (PLWNT) Qigong
Number of subjects: 90
Study 32787361 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 90
Study 32078503 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention centers with hydration stations, water testing services, reusable water bottles, and water promotion and education training
Number of subjects: 28
Study 32078503 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention centers
Number of subjects: 28
Study 32078503 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention sites
Number of subjects: 28
Study 32078503 — intervention group
Group type: COMPARATOR
Intervention: Control centers
Number of subjects: 28
Study 32711943 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly designed oblique stabilizers
Number of subjects: 30
Study 32711943 — intervention group
Group type: COMPARATOR
Intervention: Standard perpendicular stabilizers
Number of subjects: 30
Study 32497261 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction-concurrent sequence (induction-PX regimen)
Number of subjects: 803
Study 32497261 — intervention group
Group type: COMPARATOR
Intervention: Induction-PX regimen
Number of subjects: 803
Study 32497261 — intervention group
Group type: COMPARATOR
Intervention: Concurrent-adjuvant sequence
Number of subjects: 803
Study 32497261 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant-PF regimen
Number of subjects: 803
Study 32497261 — intervention group
Group type: COMPARATOR
Intervention: Accelerated-fractionation group
Number of subjects: 803
Study 32497261 — intervention group
Group type: COMPARATOR
Intervention: 3-arm chemotherapy cohort
Number of subjects: 803
Study 36472596 — intervention group
Group type: EXPERIMENTAL
Intervention: Receptivity-timed frozen embryo transfer (n=381) with adjusted duration of progesterone exposure if indicated by receptivity testing.
Number of subjects: 767
Study 36472596 — intervention group
Group type: COMPARATOR
Intervention: Standard timing frozen embryo transfer (n=386) regardless of receptivity test results.
Number of subjects: 767
Study 36472596 — intervention group
Group type: EXPERIMENTAL
Intervention: Receptivity-timed frozen embryo transfer (n=381)
Number of subjects: 767
Study 36472596 — intervention group
Group type: COMPARATOR
Intervention: Standard timing frozen embryo transfer (n=386)
Number of subjects: 767
Study 35737597 — intervention group
Group type: EXPERIMENTAL
Intervention: Palmitoylethanolamide (PEA) 600 mg plus lithium and risperidone
Number of subjects: 63
Study 33059108 — intervention group
Group type: EXPERIMENTAL
Intervention: Violet LED
Number of subjects: 70
Study 33059108 — intervention group
Group type: COMPARATOR
Intervention: HP 35% without light activation
Number of subjects: 70
Study 33059108 — intervention group
Group type: COMPARATOR
Intervention: CP 16% for 4 h/day without light activation
Number of subjects: 70
Study 33059108 — intervention group
Group type: EXPERIMENTAL
Intervention: HP 35% + violet LED
Number of subjects: 70
Study 33059108 — intervention group
Group type: EXPERIMENTAL
Intervention: CP 16% for 4 h/day + violet LED
Number of subjects: 70
Study 33059108 — intervention group
Group type: EXPERIMENTAL
Intervention: HP 35% without light activation + CP 16% for 4 h/day
Number of subjects: 70
Study 33059108 — intervention group
Group type: COMPARATOR
Intervention: Artificial saliva (placebo)
Number of subjects: 70
Study 33989767 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel immuno-oncology drugs
Number of subjects: 0
Study 33989767 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitivity analyses using methods suitable under non-proportional hazards (non-PH)
Number of subjects: 0
Study 33989767 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial design and sample size calculation methods
Number of subjects: 0
Study 33989767 — intervention group
Group type: EXPERIMENTAL
Intervention: Methods for conducting sensitivity analyses for overall survival (OS)
Number of subjects: 0
Study 33538790 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 56
Study 33538790 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen plus GnRHa
Number of subjects: 56
Study 33538790 — intervention group
Group type: EXPERIMENTAL
Intervention: AI plus GnRHa
Number of subjects: 56
Study 34059016 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive behavioral therapy (CBT)‐based counseling, six in‐person sessions and two telephone sessions once per week after the 14th week of pregnancy.
Number of subjects: 56
Study 34059016 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group).
Number of subjects: 56
Study 32779610 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-expanding drug-eluting stent (DES) with a 1-mm larger diameter than the reference vessel diameter
Number of subjects: 40
Study 32779610 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-expanding drug-eluting stent (DES) with a 2-mm larger diameter than the reference vessel diameter
Number of subjects: 40
Study 34213746 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with AN
Number of subjects: 66
Study 34213746 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 66
Study 33913339 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab (60 mg every 6 months)
Number of subjects: 150
Study 33913339 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronic acid (70 mg once weekly)
Number of subjects: 150
Study 33913339 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 150
Study 33913339 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsule
Number of subjects: 150
Study 34677080 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic vessel sealer
Number of subjects: 120
Study 34677080 — intervention group
Group type: COMPARATOR
Intervention: Standard PLND using clips
Number of subjects: 120
Study 32473865 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepilex Border Post-Op
Number of subjects: 0
Study 32473865 — intervention group
Group type: COMPARATOR
Intervention: Aquacel Surgical
Number of subjects: 0
Study 34487750 — intervention group
Group type: EXPERIMENTAL
Intervention: Saroglitazar 4 mg
Number of subjects: 37
Study 34487750 — intervention group
Group type: EXPERIMENTAL
Intervention: Saroglitazar 2 mg
Number of subjects: 37
Study 34487750 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 34111832 — intervention group
Group type: EXPERIMENTAL
Intervention: Adequate fruit and vegetable intake (at least twice daily or a combination of at least five times daily)
Number of subjects: 7576
Study 34111832 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein food consumption (at least twice weekly)
Number of subjects: 7576
Study 34111832 — intervention group
Group type: EXPERIMENTAL
Intervention: Not consuming fast foods in the past week
Number of subjects: 7576
Study 34111832 — intervention group
Group type: EXPERIMENTAL
Intervention: Not consuming carbonated/sweetened drinks in the past 30 days
Number of subjects: 7576
Study 32679281 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongxinluo (TXL)
Number of subjects: 3796
Study 32679281 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3796
Study 32209913 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative study based on semi-structured phone interviews with severe trauma survivors.
Number of subjects: 340
Study 32209913 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative analysis of trauma survivors' experiences.
Number of subjects: 340
Study 32434761 — intervention group
Group type: EXPERIMENTAL
Intervention: Eliminating the Stigma of Differences (ESD)
Number of subjects: 416
Study 32434761 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control
Number of subjects: 416
Study 32434761 — intervention group
Group type: COMPARATOR
Intervention: Comparator interventions (contact with young adults with mental illness and exposure to antistigma printed materials)
Number of subjects: 416
Study 32610815 — intervention group
Group type: EXPERIMENTAL
Intervention: Public meetings and elections
Number of subjects: 10
Study 32610815 — intervention group
Group type: EXPERIMENTAL
Intervention: Elections for governance committee members
Number of subjects: 10
Study 34092603 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation and instrument-assisted soft tissue mobilization combined treatment (TICT)
Number of subjects: 32
Study 34092603 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study 36172716 — intervention group
Group type: EXPERIMENTAL
Intervention: Home hand therapy
Number of subjects: 105
Study 36172716 — intervention group
Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 105
Study 33929389 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (2, 5, 10, and 20 mmol/L)
Number of subjects: 0
Study 33929389 — intervention group
Group type: COMPARATOR
Intervention: Hypoxia
Number of subjects: 0
Study 33929389 — intervention group
Group type: COMPARATOR
Intervention: siPrkaa1
Number of subjects: 0
Study 33929389 — intervention group
Group type: COMPARATOR
Intervention: Control small interfering RNA
Number of subjects: 0
Study 32389532 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (24 weeks of hour-long, twice-weekly classes including strength training, aerobic exercise, nutrition education, and civic engagement activities)
Number of subjects: 182
Study 32389532 — intervention group
Group type: COMPARATOR
Intervention: Control group (delayed intervention, received the program after 24-week outcome assessment)
Number of subjects: 182
Study 35405991 — intervention group
Group type: EXPERIMENTAL
Intervention: Wine (27 g of alcohol/day for 8 weeks)
Number of subjects: 64
Study 35405991 — intervention group
Group type: COMPARATOR
Intervention: Ethanol (27 g of alcohol/day for 8 weeks)
Number of subjects: 64
Study 35405991 — intervention group
Group type: COMPARATOR
Intervention: No alcohol (control group)
Number of subjects: 64
Study 32620174 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive oscillating device (NIOD) for chest physiotherapy
Number of subjects: 50
Study 32620174 — intervention group
Group type: COMPARATOR
Intervention: Standard chest physiotherapy (CPT)
Number of subjects: 50
Study 32620174 — intervention group
Group type: EXPERIMENTAL
Intervention: NIOD
Number of subjects: 50
Study 32620174 — intervention group
Group type: COMPARATOR
Intervention: CPT
Number of subjects: 50
Study 33184627 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy deficit (DEF) at 45% of total daily energy expenditure
Number of subjects: 10
Study 33184627 — intervention group
Group type: COMPARATOR
Intervention: Energy matched (BAL) to individual estimated total daily energy expenditure (±10%)
Number of subjects: 10
Study 35468458 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation problem-based learning for cesarean section maternity nursing
Number of subjects: 93
Study 35468458 — intervention group
Group type: COMPARATOR
Intervention: Conventional type of maternity nursing clinical practice
Number of subjects: 93
Study 32460241 — intervention group
Group type: EXPERIMENTAL
Intervention: NZBC extract (600 mg/day for 7 days)
Number of subjects: 12
Study 32460241 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 34954585 — intervention group
Group type: COMPARATOR
Intervention: Laser posterior cordotomy
Number of subjects: 40
Study 34954585 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined laser posterior cordotomy with suture lateralization
Number of subjects: 40
Study 34762376 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal acupoint thread embedding therapy combined with donepezil hydrochloride tablets (5 mg per day)
Number of subjects: 60
Study 34762376 — intervention group
Group type: COMPARATOR
Intervention: Donepezil hydrochloride tablets (5 mg per day)
Number of subjects: 60
Study 32389658 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran dual therapy (110 mg or 150 mg twice daily)
Number of subjects: 2725
Study 32389658 — intervention group
Group type: COMPARATOR
Intervention: Warfarin triple therapy (warfarin, aspirin, and a P2Y12 platelet inhibitor)
Number of subjects: 2725
Study 32389658 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran dual therapy
Number of subjects: 2725
Study 32389658 — intervention group
Group type: COMPARATOR
Intervention: Warfarin triple therapy
Number of subjects: 2725
Study 35611667 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic containing Lactobacillus paracasei DKGF1 and Opuntia humifusa, administered once a day for 4 weeks
Number of subjects: 67
Study 35611667 — intervention group
Group type: COMPARATOR
Intervention: Placebo, administered once a day for 4 weeks
Number of subjects: 67
Study 35611667 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic
Number of subjects: 67
Study 35611667 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 33934443 — intervention group
Group type: EXPERIMENTAL
Intervention: Silymarin with Fingolimod (FTY720)
Number of subjects: 48
Study 33934443 — intervention group
Group type: COMPARATOR
Intervention: Placebo with Fingolimod (FTY720)
Number of subjects: 48
Study 33386898 — intervention group
Group type: EXPERIMENTAL
Intervention: adalimumab plus methotrexate
Number of subjects: 180
Study 33386898 — intervention group
Group type: COMPARATOR
Intervention: placebo plus methotrexate
Number of subjects: 180
Study 34352125 — intervention group
Group type: EXPERIMENTAL
Intervention: Triangular neck (TN) implants
Number of subjects: 20
Study 34352125 — intervention group
Group type: COMPARATOR
Intervention: Round neck (RN) implants
Number of subjects: 20
Study 34352125 — intervention group
Group type: COMPARATOR
Intervention: Both TN and RN implants
Number of subjects: 20
Study 33278083 — intervention group
Group type: EXPERIMENTAL
Intervention: Air inflation
Number of subjects: 25
Study 33278083 — intervention group
Group type: COMPARATOR
Intervention: Optisol GS storage media
Number of subjects: 25
Study 33278083 — intervention group
Group type: EXPERIMENTAL
Intervention: PDEK bubbling
Number of subjects: 25
Study 32077550 — intervention group
Group type: EXPERIMENTAL
Intervention: Anlotinib
Number of subjects: 437
Study 32077550 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 437
Study 35168964 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy food prescription incentive (n=297) with a weekly incentive of CDN$10.50/household member for 6 months
Number of subjects: 594
Study 35168964 — intervention group
Group type: COMPARATOR
Intervention: Healthy food prescription comparison group (n=297)
Number of subjects: 594
Study 35320229 — intervention group
Group type: EXPERIMENTAL
Intervention: High-force lumbar traction, hot pack, and lumbar stabilisation exercises (group 1)
Number of subjects: 30
Study 35320229 — intervention group
Group type: COMPARATOR
Intervention: Low-force lumbar traction, hot pack, and lumbar stabilisation exercises (group 2)
Number of subjects: 30
Study 32233905 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating Attitudes Test
Number of subjects: 385
Study 36567637 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 L polyethylene glycol plus ascorbic acid with 24 mg senna (1L-PEG/AS)
Number of subjects: 344
Study 36567637 — intervention group
Group type: COMPARATOR
Intervention: 2 L polyethylene glycol plus ascorbic acid (2L-PEG/A)
Number of subjects: 344
Study 33675247 — intervention group
Group type: EXPERIMENTAL
Intervention: PsyCovidApp intervention
Number of subjects: 440
Study 33675247 — intervention group
Group type: COMPARATOR
Intervention: Control App intervention
Number of subjects: 440
Study 32731903 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia (no specific dosage or duration mentioned)
Number of subjects: 26
Study 35216581 — intervention group
Group type: EXPERIMENTAL
Intervention: Veverimer
Number of subjects: 77
Study 35216581 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 33090189 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical coherence tomography (OCT) measures of the optic nerve head and macula
Number of subjects: 104
Study 35895770 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/kg CBD in oil (oral)
Number of subjects: 8
Study 35895770 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg CBD in DMSO (IV)
Number of subjects: 8
Study 35895770 — intervention group
Group type: COMPARATOR
Intervention: Control (no CBD)
Number of subjects: 8
Study 34265631 — intervention group
Group type: EXPERIMENTAL
Intervention: N95 facemasks
Number of subjects: 52
Study 32722729 — intervention group
Group type: EXPERIMENTAL
Intervention: NSI-189 80-mg dose
Number of subjects: 220
Study 32722729 — intervention group
Group type: EXPERIMENTAL
Intervention: NSI-189 40-mg dose
Number of subjects: 220
Study 32722729 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study 32722729 — intervention group
Group type: EXPERIMENTAL
Intervention: NSI-189 (both doses)
Number of subjects: 220
Study 36294918 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal administration of mometasone furoate twice daily along with olfactory training
Number of subjects: 86
Study 36294918 — intervention group
Group type: COMPARATOR
Intervention: Olfactory training only (Control)
Number of subjects: 86
Study 33852250 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboxytherapy gel mask
Number of subjects: 10
Study 33852250 — intervention group
Group type: COMPARATOR
Intervention: Petroleum-based lanolin-containing ointment
Number of subjects: 10
Study 35236066 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Cryotherapy (TCT)
Number of subjects: 62
Study 35236066 — intervention group
Group type: COMPARATOR
Intervention: Total Cryotherapy (TCT) + Transcranial Magnet Therapy
Number of subjects: 62
Study 33259351 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 112
Study 33259351 — intervention group
Group type: COMPARATOR
Intervention: Social Support Group (SSG)
Number of subjects: 112
Study 32629785 — intervention group
Group type: EXPERIMENTAL
Intervention: Injury-induced Dupuytren's contracture (DC)
Number of subjects: 132
Study 32629785 — intervention group
Group type: COMPARATOR
Intervention: Injury-unrelated Dupuytren's contracture (DC)
Number of subjects: 132
Study 36128988 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular cognitive behavioral therapy (M-CBT)
Number of subjects: 216
Study 36128988 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 216
Study 33684086 — intervention group
Group type: EXPERIMENTAL
Intervention: KDIGO bundle implementation
Number of subjects: 278
Study 33684086 — intervention group
Group type: COMPARATOR
Intervention: Control group (no KDIGO bundle)
Number of subjects: 278
Study 32868016 — intervention group
Group type: EXPERIMENTAL
Intervention: IN.PACT drug-coated balloon (DCB)
Number of subjects: 331
Study 32868016 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 331
Study 34264782 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric heavy resistance training of the injured region
Number of subjects: 30
Study 34264782 — intervention group
Group type: COMPARATOR
Intervention: Control exercises of the back and abdominal muscle
Number of subjects: 30
Study 33168806 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational attainment (EA)
Number of subjects: 815000
Study 33168806 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive performance (CP)
Number of subjects: 815000
Study 34889205 — intervention group
Group type: COMPARATOR
Intervention: Finasteride (placebo-controlled)
Number of subjects: 0
Study 34889205 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum steroid levels
Number of subjects: 0
Study 34889205 — intervention group
Group type: EXPERIMENTAL
Intervention: IGF1 axis
Number of subjects: 0
Study 32545534 — intervention group
Group type: COMPARATOR
Intervention: Standard self-regulation program (control group)
Number of subjects: 0
Study 32816246 — intervention group
Group type: EXPERIMENTAL
Intervention: Brigatinib (oral tyrosine kinase inhibitor)
Number of subjects: 442
Study 32476558 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based education and counselling for 6 months (first 3 months education, next 3 months counselling)
Number of subjects: 80
Study 32476558 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 80
Study 34724257 — intervention group
Group type: COMPARATOR
Intervention: Rasagiline 1 mg/day over 12 months
Number of subjects: 165
Study 34637478 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education sessions and home support program
Number of subjects: 125
Study 34637478 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 125